Powerful Medical
13. April 2023

QOF NHS: Maximize your AFib earnings in 2023/24 

What is QOF in NHS

In the United Kingdom, the Quality and Outcomes Framework (QOF) is a program that has been designed to evaluate the performance of National Health Service (NHS) GP practices. The QOF provides a financial incentive for GP practices to deliver high-quality healthcare services and improve patient outcomes. To achieve this, the QOF allocates points to GP practices for meeting specific targets related to patient care.

Source: Quality and Outcomes Framework guidance for 2023/24

Improve your QOF score by stellar AFib detection

The QOF plays a significant role in the financial health of NHS GP practices, as it directly impacts their income. The more QOF points a practice earns, the higher its income will be. Therefore, earning QOF points is important not only for improving patient care but also for the financial sustainability of GP practices. This blog post will explore how GP practices can leverage PMcardio’s accurate and timely AI-powered ECG interpretation including AFib detection capabilities to increase their QOF earnings.

QOF NHS: Maximize your AFib earnings in 2023/24 

QOF in NHS: Payment Calculation and Analysis System

Within the framework of the General Medical Services contract’s Quality and Outcomes Framework (QOF), the process of recording achievement is managed through the Payment Calculation and Analysis System (PCAS). Results find their way into this system by two means: an automatic extraction from patients’ electronic health records within GP clinical systems or manual input. Critical to this process, datasets and accompanying business rules provide a structured framework that outlines the logic and sequence governing the extraction of numerator and denominator data for the determination of indicator achievement. 

QOF NHS: Maximize your AFib earnings in 2023/24 
QOF NHS: Maximize your AFib earnings in 2023/24 

Read your next ECG with AI

Join a future where cardiac care is smarter, quicker, and within everyone’s reach. Sign up today and claim your 5 free ECG reports – no credit card needed. 

AFib in the Clinical Domain: Rationale for Its Inclusion in QOF

Atrial fibrillation (Afib or AF) stands as the most prevalent heart rhythm disorder, impacting about 2% of the adult population, with indications that its incidence is on the rise. Afib can manifest as palpitations and breathlessness in many individuals, but it can also remain asymptomatic, eluding detection. If left untreated, Afib poses a substantial risk for stroke, contributing to an estimated 20% of all strokes, along with increased mortality and significant morbidity. This condition tends to affect men more frequently than women and becomes more prevalent with age and in conjunction with heart disease, diabetes, obesity, and hypertension.

QOF 2023/24: Afib Indicator set

QOF NHS: Maximize your AFib earnings in 2023/24 
Source: Quality and Outcomes Framework guidance for 2023/24

AFib QOF earnings in 2023/24  

For the 2023/24 year, the average QOF point value is £213.43. With a practice size of 10,000 patients, this would make the maximum potential earnings from these earnings £6,189.47 per year. To calculate this for your appropriate practice size, the Contractor Population Index (CPI) is a tool that adjusts your QOF payments based on the relevant size of your practice’s patient list. 

Improve your QOF earnings with PMcardio

PMcardio’s AI-powered ECG analysis is revolutionising the diagnosis of A-Fib, achieving an impressive 97% sensitivity and 99% specificity. With 5x better diagnostic precision when compared to the current state-of-the-art, GP practices can more effectively identify patients suffering from A-Fib, ensuring they receive the appropriate management and treatment in a timely manner.

PMcardio not only excels in diagnostics but also assists healthcare professionals by calculating the CHA2DS2-VASc score and providing recommendations for anticoagulation therapy. These recommendations adhere to established guidelines, ensuring that patients receive the most appropriate treatment. 

QOF NHS: Maximize your AFib earnings in 2023/24 
QOF NHS: Maximize your AFib earnings in 2023/24 

Stay on the pulse with our newsletter

Your submission was successful

QOF indicators seamless alignment with PM cardio

This comprehensive approach to patient care directly corresponds to QOF indicators, making PMcardio an invaluable tool for healthcare providers seeking to improve their practice’s performance and quality of care in managing A-Fib patients. Additionally, by using PMcardio to diagnose and manage A-Fib patients, GP practices have the potential to achieve maximum QOF points in relation to A-Fib, leading to increased earnings.

Utilizing PMcardio for the diagnosis and management of patients with atrial fibrillation, GP practices can unlock the potential to attain the highest possible QOF points for AFib, resulting in maximizing their earnings.

QOF NHS: Maximize your AFib earnings in 2023/24 
Source: Quality and Outcomes Framework guidance for 2023/24

Elevate your practice with PMcardio

Utilizing advanced algorithms and data-driven insights, PMcardio’s AI system streamlines the diagnostic process. This improved diagnostic capability not only benefits individual patients but also contributes to overall public health by promoting early intervention and better management of this common yet potentially serious cardiovascular condition. The accurate and efficient identification of A-Fib cases can help reduce the burden on healthcare systems by enabling targeted interventions and reducing the risk of complications, such as stroke or heart failure. Give PM cardio a try and get your first 5 ECGs for free.

Powerful Medical

Powerful Medical leads one of the most important shifts in modern medicine by augmenting human-made clinical decisions with artificial intelligence. Our primary focus is on cardiovascular diseases, the world’s leading cause of death.
Powerful Medical leads one of the most important shifts in modern medicine by augmenting human-made clinical decisions with artificial intelligence. Our primary focus is on cardiovascular diseases, the world’s leading cause of death.
About PMcardio:

PMcardio is the market leader in AI-powered diagnostics, addressing the world’s leading cause of death – cardiovascular diseases. The innovative clinical assistant empowers healthcare professionals to detect up to 40 cardiovascular diseases. In the form of a smartphone application, the certified Class IIb medical device interprets any 12-lead ECG image in under 5 seconds to provide accurate diagnoses and individualized treatment recommendations tailored to each patient.

Share this article

Don't miss these

Wellens syndrom ECG - Blog

Facing Wellens’ Syndrome: Are You Prepared to Prevent Acute Coronary Occlusions?

Wellens' Syndrome is a condition representing a reperfusion state post coronary artery occlusion, marked by distinctive ECG changes. This condition demands urgent recognition and intervention to prevent the progression to an extensive anterior wall myocardial infarction (MI).

Gearing Up for the US Market: PMcardio Showcases at ACC.24

We're thrilled to share our experience at the American College of Cardiology's 24th annual meeting (ACC.24) in Atlanta, where we showcased our AI-powered ECG interpretation platform

Join 25,000 healthcare professionals who are already taking advantage of AI